Valacyclovir With Cephalexin for Herpes Simplex Virus Infection
Coadministration of oral valacyclovir with oral cephalexin shows minimal interaction affecting valacyclovir exposure. [1]
Evidence for Cephalexin–Valacyclovir Pharmacokinetic Interaction
- A pharmacokinetic study evaluated the potential interaction between valacyclovir and cephalexin. [1]
- Co-administration of the two hPEPT1 substrates minimally reduced acyclovir exposure (valacyclovir is converted to acyclovir), supporting minimal impact on valacyclovir absorption. [1]
Clinical Implication for Concurrent Use
- Concurrent use of cephalexin and valacyclovir is not expected to substantially reduce valacyclovir absorption based on the available pharmacokinetic interaction data. [1]
Medication Administration Considerations
- Standard dosing schedules for both medications are appropriate when no other interacting drugs or contraindications are present. [1]
When Additional Caution Is Typically Warranted
- Additional monitoring is appropriate when patient-specific factors increase risk of adverse effects from valacyclovir (for example, baseline kidney impairment), although those risks are not assessed in the interaction study data. [1]
Common Pitfalls to Avoid
- Avoid assuming a clinically meaningful interaction solely based on both drugs being peptide-transport (hPEPT1) substrates, since the observed interaction between cephalexin and valacyclovir was minimal. [1]
Practical Recommendation
- Valacyclovir can be taken while being treated with cephalexin for herpes simplex virus infection, with the expectation of minimal pharmacokinetic interaction. [1]